Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.
| Brand name | IBUPROFEN |
| Generic name | IBUPROFEN |
| Active ingredient(s) | IBUPROFEN |
| Distributed by / for | Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532 |
| NDC | 51672-1385-8 |
| Full product label | Ibuprofen Oral Suspension USP, 100 mg/5 mL, 4 fl. oz., (118 mL), Rx only, Manufactured by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1385-8 |
| Recalling firm | Taro Pharmaceuticals U.S.A., Inc. |
| Distribution | U.S.A. Nationwide |
| Quantity | 138,886 bottles |
| Recall initiated | 2019-09-27 |
| Report date | 2019-11-06 |
| Recall completed | 2023-08-31 |
| Recall number | D-0298-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Hawthorne NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗